Biosimulation Market: Use of Biosimulation Solution for Pediatric Drug Development
Factors such as increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets are driving the growth of the market.Market Revenue Growth Analysis:The global biosimulation...
Biosimulation Market is Projected to Reach $2,881 billion by 2022
The
global biosimulation
market is projected to reach USD 2,881 billion by 2022 from USD 1,375
billion in 2017, at a CAGR of 15.9%. Factors such as increase in R&D
investments in the pharmaceutical and biotechnology industries, growing
adoption of biosimulation software by regulatory bodies, technologically
advanced QSP systems, need to curtail drug discovery and development costs,...